[No title available]

Affiliations

Comment

Aaron J Ruberto et al. Ann Emerg Med. 2021 May.

. 2021 May;77(5):555-556.

doi: 10.1016/j.annemergmed.2020.12.018.

¹ Department of Emergency Medicine, Queen's University, Kingston, Ontario, Canada.

No abstract available

Comment on

Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Ruberto AJ, Sivilotti MLA, Forrester S, Hall AK, Crawford FM, Day AG. Ruberto AJ, et al. Ann Emerg Med. 2021 Jun;77(6):613-619. doi: 10.1016/j.annemergmed.2020.08.021. Epub 2020 Nov 5. Ann Emerg Med. 2021. PMID: 33160719 Clinical Trial.
Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
Moussa G, Genest M, Villeneuve E, Wang JJ. Moussa G, et al. Ann Emerg Med. 2021 May;77(5):555. doi: 10.1016/j.annemergmed.2020.12.016. Ann Emerg Med. 2021. PMID: 33902836 No abstract available.